Home / Companies / Novo Nordisk Pharmaceutical Industries LP

Novo Nordisk Pharmaceutical Industries LP FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection NAI · Jun 30, 2026
No warning letters matched by name

Inspections 13

0 OAI

Recalls 0 0 Class I

Warning letters 0 None on file

510(k) clearances 0 None on file

Novo Nordisk Pharmaceutical Industries LP has 0 FDA recalls, 13 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Novo Nordisk Pharmaceutical Industries LP" is on file. FDA has published 1 Form 483 for Novo Nordisk Pharmaceutical Industries LP.

What these totals cover: FDA records filed under the name "Novo Nordisk Pharmaceutical Industries LP" and its spelling variant "Novo Nordisk Pharmaceutical Industries".

Latest inspection: Jun 30, 2026 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	13	Nov 15, 2026	Newest record Nov 5, 2026	Current
Compliance actions	0	Nov 2, 2026	Newest record Oct 29, 2026	Current

FDA record by year

Novo Nordisk Pharmaceutical Industries LP's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Novo Nordisk Pharmaceutical Industries LP: FDA inspections per year

Year	Inspections	OAI	Warning letters	Recall records	Class I
2026	1	0	0	0	0
2025	2	0	0	0	0
2024	0	0	0	0	0
2023	1	0	0	0	0
2022	0	0	0	0	0
2021	0	0	0	0	0
2020	0	0	0	0	0
2019	0	0	0	0	0
2018	2	0	0	0	0
2017	0	0	0	0	0

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Novo Nordisk Pharmaceutical Industries LP as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novo Nordisk Pharmaceutical Industries LP yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Novo Nordisk Pharmaceutical Industries LP Form 483s

1 Form 483 published by FDA.

Date	Document	FEI
Jul 13, 2023 · Document on fda.gov	483	1000158576

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent FDA inspections

13 inspections from Sep 2, 2009 to Jun 30, 2026.

Date	Site	Product	Classification	FEI
Jun 30, 2026	Petersburg, VA	Drugs	No Action Indicated (NAI)	3033953703
Jul 30, 2025	Durham, NC	Drugs	No Action Indicated (NAI)	3016799712
Jun 13, 2025	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Dec 20, 2023	Durham, NC	Drugs	No Action Indicated (NAI)	3016799712
Dec 20, 2018	Durham, NC	Drugs	No Action Indicated (NAI)	3016799712
Jan 12, 2018	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Dec 1, 2016	Durham, NC	Drugs	No Action Indicated (NAI)	3016799712
Jan 28, 2016	Clayton, NC	Devices	No Action Indicated (NAI)	1000158576
Aug 21, 2014	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Aug 16, 2012	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Jul 1, 2011	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Sep 3, 2010	Clayton, NC	Drugs	No Action Indicated (NAI)	1000158576
Sep 2, 2009	Clayton, NC	Drugs	Voluntary Action Indicated (VAI)	1000158576

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

3 inspected sites, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3033953703	Petersburg, VA	1	Jun 30, 2026
FEI 3016799712	Durham, NC	4	Jul 30, 2025
FEI 1000158576	Clayton, NC	8	Jun 13, 2025

Novo Nordisk Pharmaceutical Industries LP and the FDA: common questions

Has Novo Nordisk Pharmaceutical Industries LP received an FDA warning letter?

No FDA warning letter addressed to the name "Novo Nordisk Pharmaceutical Industries LP" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Novo Nordisk Pharmaceutical Industries LP received an FDA Form 483?

FDA has published 1 Form 483 for Novo Nordisk Pharmaceutical Industries LP in its reading room, the most recent dated Jul 13, 2023. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Novo Nordisk Pharmaceutical Industries LP?

The most recent FDA inspection on file ended Jun 30, 2026 at Petersburg, VA and was classified NAI. FDA has 13 inspections of Novo Nordisk Pharmaceutical Industries LP on file.

Need more than this page shows? Ask about Novo Nordisk Pharmaceutical Industries LP in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.